$TOMZ
TOMI Environmental Solutions, Inc. Stock $tomz

$tomz Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000165495424006405 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$3.013M	$1.114M	$1.528M
YoY Change	8.6%	-29.58%	-45.66%
Cost Of Revenue	$1.159M	$443.4K	$688.6K
YoY Change	7.86%	-30.82%	-40.84%
Gross Profit	$1.855M	$670.7K	$839.1K
YoY Change	9.07%	-28.75%	-49.07%
Gross Profit Margin	61.54%	60.2%	54.93%
Selling, General & Admin	$1.571M	$1.638M	$1.552M
YoY Change	8.8%	-13.57%	-26.28%
% of Gross Profit	84.74%	244.18%	184.94%
Research & Development	$61.61K	$67.97K	$271.2K
YoY Change	-16.43%	-3.61%	177.79%
% of Gross Profit	3.32%	10.13%	32.32%
Depreciation & Amortization	$71.68K	$73.04K	$93.41K
YoY Change	-17.39%	-14.07%	14.61%
% of Gross Profit	3.86%	10.89%	11.13%
Operating Expenses	$1.733M	$1.897M	$2.010M
YoY Change	-3.16%	-10.91%	-14.58%
Operating Profit	$121.8K	-$1.226M	-$1.171M
YoY Change	-236.96%	3.23%	65.9%
Interest Expense	$93.46K	$93.62K	-$54.58K
YoY Change	26602.57%	14084.85%	-6232.58%
% of Operating Profit	76.72%
Other Income/Expense, Net	-$91.61K	-$83.71K
YoY Change	-26350.43%	-12803.19%
Pretax Income	$30.20K	-$1.310M	-$1.226M
YoY Change	-134.09%	10.33%	73.85%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$30.20K	-$1.310M	-$1.226M
YoY Change	-134.09%	10.33%	73.85%
Net Earnings / Revenue	1.0%	-117.6%	-80.24%
Basic Earnings Per Share	$0.00	-$0.07
Diluted Earnings Per Share	$0.00	-$0.07	-$0.06
COMMON SHARES
Basic Shares Outstanding	19.96M shares	19.96M shares	19.82M shares
Diluted Shares Outstanding	22.13M shares	19.95M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$709.1K	$1.093M	$2.339M
YoY Change	-54.95%	-55.73%	-39.51%
Cash & Equivalents	$709.1K	$1.093M	$2.339M
Short-Term Investments
Other Short-Term Assets	$416.4K	$508.4K	$400.6K
YoY Change	-15.83%	-2.35%	-52.04%
Inventory	$4.282M	$4.646M	$4.627M
Prepaid Expenses	$290.2K	$384.0K	$371.3K
Receivables	$3.664M	$2.116M	$2.430M
Other Receivables	$164.2K	$164.2K	$164.1K
Total Short-Term Assets	$9.235M	$8.527M	$9.961M
YoY Change	-7.88%	-18.04%	-17.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$983.6K	$1.061M	$1.517M
YoY Change	-20.56%	-16.79%	13.57%
Goodwill
YoY Change
Intangibles	$1.944M	$1.949M	$1.954M
YoY Change	6.91%	90.73%	7.0%
Long-Term Investments
YoY Change
Other Assets	$638.4K	$593.9K	$550.7K
YoY Change	12.88%	14.07%	15.91%
Total Long-Term Assets	$3.376M	$3.431M	$3.397M
YoY Change	1.66%	2.97%	0.94%
TOTAL ASSETS
Total Short-Term Assets	$9.235M	$8.527M	$9.961M
Total Long-Term Assets	$3.376M	$3.431M	$3.397M
Total Assets	$12.61M	$11.96M	$13.36M
YoY Change	-5.51%	-12.95%	-13.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.714M	$1.351M	$1.267M
YoY Change	26.02%	5.44%	-28.08%
Accrued Expenses	$635.1K	$591.4K	$791.2K
YoY Change	-15.93%	-6.86%	-4.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.407M	$1.956M	$2.058M
YoY Change	6.39%	-22.83%	-37.45%
LONG-TERM LIABILITIES
Long-Term Debt	$2.329M	$2.314M	$2.298M
YoY Change
Other Long-Term Liabilities	$579.7K	$612.0K	$642.5K
YoY Change	-17.42%	-16.27%	-15.58%
Total Long-Term Liabilities	$2.909M	$2.926M	$2.941M
YoY Change	314.4%	300.27%	286.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.407M	$1.956M	$2.058M
Total Long-Term Liabilities	$2.909M	$2.926M	$2.941M
Total Liabilities	$5.316M	$4.882M	$4.999M
YoY Change	79.33%	49.48%	23.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$51.11M	-$51.14M	-$49.83M
YoY Change	7.14%	7.4%	7.33%
Common Stock	$200.2K	$199.6K	$199.2K
YoY Change	0.96%	0.66%	0.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.296M	$7.076M	$8.359M
YoY Change
Total Liabilities & Shareholders Equity	$12.61M	$11.96M	$13.36M
YoY Change	-5.51%	-12.95%	-13.82%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	$30.20K	-$1.310M	-$1.226M
YoY Change	-134.09%	10.33%	73.85%
Depreciation, Depletion And Amortization	$71.68K	$73.04K	$93.41K
YoY Change	-17.39%	-14.07%	14.61%
Cash From Operating Activities	-$379.7K	-$1.178M	-$1.237M
YoY Change	-54.53%	-13.56%	304.9%
INVESTING ACTIVITIES
Capital Expenditures	$4.440K	$94.84K	$122.4K
YoY Change	-92.63%	178.24%	-25.04%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$4.440K	-$94.84K	-$122.4K
YoY Change	-92.63%	178.24%	-25.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$27.50K	2.288M
YoY Change
NET CHANGE
Cash From Operating Activities	-379.7K	-$1.178M	-1.237M
Cash From Investing Activities	-4.440K	-$94.84K	-122.4K
Cash From Financing Activities	0.000	$27.50K	2.288M
Net Change In Cash	-384.1K	-$1.246M	928.4K
YoY Change	-57.09%	-10.85%	-298.05%
FREE CASH FLOW
Cash From Operating Activities	-$379.7K	-$1.178M	-$1.237M
Capital Expenditures	$4.440K	$94.84K	$122.4K
Free Cash Flow	-$384.1K	-$1.273M	-$1.359M
YoY Change	-57.09%	-8.88%	189.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	384003	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	371298	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1060640	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1048642	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	451514	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2925651	usd
CY2024Q1	us-gaap	Liabilities Liabilities	4881864	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4998720	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	199553	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51136419	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	7076204	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	29335	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9960874	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1123246	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2940542	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11958068	usd
CY2024Q1	us-gaap	Deposits Deposits	124427	usd
CY2024Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	458651	usd
CY2024Q1	tomz	Equipments Equipments	2269185	usd
CY2024Q1	us-gaap	Public Utilities Property Plant And Equipment Vehicles PublicUtilitiesPropertyPlantAndEquipmentVehicles	66170	usd
CY2024Q1	tomz	Computer Software ComputerSoftware	307563	usd
CY2024Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	393381	usd
CY2024Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	405000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	10470546	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2115691	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1351118	usd
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	472525	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	675491	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	118911	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115658	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1956213	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2058178	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	612017	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	642527	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8358894	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	164150	usd
CY2023Q4	tomz	Inventory Current InventoryCurrent	4627103	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	467935	usd
CY2023Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	206240	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	550677	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	2348098	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1267029	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	57985245	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-49826229	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8358894	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13357614	usd
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000314227
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19923955	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19955205	shares
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	30000	usd
CY2023Q4	tomz	Common Stock Issuable Upon Conversion Of Outstanding Shares CommonStockIssuableUponConversionOfOutstandingShares	63750	shares
CY2023Q1	tomz	Amortization Of Tenant Improvement Allowance AmortizationOfTenantImprovementAllowance	9798	usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-09908
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	TOMI Environmental Solutions, Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-1947988
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	8430 Spires Way
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Frederick
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	21701
CY2024Q1	dei	City Area Code CityAreaCode	800
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	525-1698
CY2024Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.01 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	TOMZ
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19955205	shares
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1093219	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2339059	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2429929	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	164150	usd
CY2024Q1	tomz	Inventory Current InventoryCurrent	4645885	usd
CY2024Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	124427	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	8527375	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1118369	usd
CY2024Q1	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	206240	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	593930	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	2370053	usd
CY2024Q1	us-gaap	Assets Assets	11958068	usd
CY2023Q4	us-gaap	Assets Assets	13357614	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13659	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	286366	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	301985	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2313634	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2298015	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19955205	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19923955	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	199240	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	58012432	usd
CY2024Q1	us-gaap	Revenues Revenues	1114087	usd
CY2023Q1	us-gaap	Revenues Revenues	1582172	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	443419	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	640935	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	670668	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	941237	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	197999	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	137185	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	77921	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	88776	usd
CY2024Q1	us-gaap	Selling Expense SellingExpense	289069	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	376653	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	67971	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	70520	usd
CY2024Q1	us-gaap	Legal Fees LegalFees	113635	usd
CY2023Q1	us-gaap	Legal Fees LegalFees	75455	usd
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1150549	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1380794	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1897144	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2129383	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1226476	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1188146	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	9906	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	659	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	93620	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	0	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-83714	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	659	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1310190	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1187487	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1310190	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1187487	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19954511	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19806622	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19954511	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19806622	shares
CY2024Q1	tomz	Warrants And Options Exercised Amount WarrantsAndOptionsExercisedAmount	27500	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1310190	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	7076204	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11448200	usd
CY2023Q1	tomz	Equity Compensation EquityCompensation	158833	usd
CY2023Q1	tomz	Common Stock Issued For Services Provided Amount CommonStockIssuedForServicesProvidedAmount	51000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1187487	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1310190	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1187487	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	77921	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	88776	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	39329	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	39329	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	15620	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2024Q1	tomz	Equity Compensation Expense EquityCompensationExpense	0	usd
CY2023Q1	tomz	Equity Compensation Expense EquityCompensationExpense	158833	usd
CY2024Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	51000	usd
CY2024Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	96620	usd
CY2023Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	0	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-410858	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-281653	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18782	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-142541	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	12705	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	24616	usd
CY2024Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-95093	usd
CY2023Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-67151	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	43253	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	45581	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	84090	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-518441	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-202966	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-161769	usd
CY2024Q1	tomz	Customer Deposits CustomerDeposits	13659	usd
CY2023Q1	tomz	Customer Deposits CustomerDeposits	-81243	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-40367	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-39191	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1178499	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1363347	usd
CY2024Q1	tomz	Payment To Acquire Property Plant And Equipment PaymentToAcquirePropertyPlantAndEquipment	-94840	usd
CY2023Q1	tomz	Payment To Acquire Property Plant And Equipment PaymentToAcquirePropertyPlantAndEquipment	-34086	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-94840	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-34086	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27500	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27500	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1245840	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1397433	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2339059	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3866733	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1093219	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2469300	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	49000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1. DESCRIPTION OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">TOMI Environmental Solutions, Inc., a Florida corporation (“TOMI”, the “Company”, “we”, “our” and “us”) is a global provider of disinfection and decontamination essentials through our premier Binary Ionization Technology® (BIT™) platform, under which we manufacture, license, service and sell our SteraMist® brand of products, including SteraMist® BIT™, a hydrogen peroxide-based mist and fog. Our solution and process are environmentally friendly as the only biproduct from our decontamination process is oxygen and water in the form of humidity. Our solution is organically listed in the United States and Canada as a sustainably green product with no or very little carbon footprint. Our business is organized into five divisions: Life Sciences, Healthcare, TOMI Service Network, Food Safety and Commercial.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Invented under a defense grant in association with the Defense Advanced Research Projects Agency (“DARPA”) of the U.S. Department of Defense, BIT™ is registered with the U.S. Environmental Protection Agency (the “EPA”) and uses a low percentage hydrogen peroxide as its only active ingredient to produce a fog composed mostly of a hydroxyl radical (<strong><sup style="vertical-align:super">.</sup></strong>OH ion), known as ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Our products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, bio-safety labs, pharmaceutical facilities, meat and produce processing facilities, universities and research facilities, vivarium labs, other service industries including cruise ships, office buildings, hotel and motel rooms, schools, restaurants, military barracks, police and fire departments, prisons, and athletic facilities. Our products are also used in single-family homes and multi-unit residences. Additionally, our products have been listed on the EPA’s List N as products that help combat COVID-19 and are actively being used for this purpose.</p>
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Certain reclassifications have been made to prior-year comparative financial statements to conform to the current year presentation. These reclassifications had no material effect on previously reported results of operations or financial position.</p>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the accompanying consolidated financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, inventory, fair values of financial instruments, intangible assets, useful lives of intangible assets and property and equipment, fair values of stock-based awards, income taxes, and contingent liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of our assets and liabilities.</p>
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	88000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	54000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1398000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1494000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	95000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	30000	usd
CY2024Q1	tomz	Common Stock Issuable Upon Conversion Of Outstanding Options CommonStockIssuableUponConversionOfOutstandingOptions	580042	shares
CY2024Q1	tomz	Common Stock Issuable Upon Conversion Of Outstanding Shares CommonStockIssuableUponConversionOfOutstandingShares	63750	shares
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2839310	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2756469	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents. We maintain cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation limit of $250,000 at times during the year.</p>
CY2024Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	92000	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	197000	usd
CY2024Q1	tomz	Research And Developments Expense ResearchAndDevelopmentsExpense	68000	usd
CY2023Q1	tomz	Research And Developments Expense ResearchAndDevelopmentsExpense	71000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3922000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3980000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	819000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	742000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	95000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	95000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	4646000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4627000	usd
CY2023Q4	us-gaap	Deposits Deposits	29335	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	364819	usd
CY2023Q4	tomz	Equipments Equipments	2269185	usd
CY2023Q4	us-gaap	Public Utilities Property Plant And Equipment Vehicles PublicUtilitiesPropertyPlantAndEquipmentVehicles	66170	usd
CY2023Q4	tomz	Computer Software ComputerSoftware	306656	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	393381	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	405000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3899950	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3805211	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1060640	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1048642	usd
CY2024Q1	us-gaap	Depreciation Depreciation	73043	usd
CY2023Q1	us-gaap	Depreciation Depreciation	85003	usd
CY2024Q1	tomz	Amortization Of Tenant Improvement Allowance AmortizationOfTenantImprovementAllowance	9798	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4878	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3773	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3196396	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3196396	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2908890	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2904013	usd
CY2024Q1	tomz	Intangible Assets Net IntangibleAssetsNet	287506	usd
CY2023Q4	tomz	Intangible Assets Net IntangibleAssetsNet	292383	usd
CY2024Q1	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	830863	usd
CY2023Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	830863	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1118369	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1123246	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	15000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	20000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	20000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	20000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	20000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	193000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	288000	usd
CY2020Q2	tomz	Proceeds From Service Contract Of Receivables ProceedsFromServiceContractOfReceivables	30409	usd
CY2020Q2	tomz	Annual Payments On Contract Term AnnualPaymentsOnContractTerm	P5Y
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	66857	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	3766	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	3766	usd
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	5000000	usd
CY2023Q4	us-gaap	Investment Sold Not Yet Purchased Balance Principal Amount InvestmentSoldNotYetPurchasedBalancePrincipalAmount	2600000	usd
CY2023Q4	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	2080000	shares
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.25
CY2023Q4	tomz	Proceeds From Convertible Promissory Notes Issuance ProceedsFromConvertiblePromissoryNotesIssuance	2600000	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.12	pure
CY2023Q4	tomz	Description Of Convertible Note DescriptionOfConvertibleNote	The Notes are convertible into shares of our Common Stock, at the option of the holder, at a conversion price of $1.25 per share, which shall not exceed $1.55 per share. In addition, we can require Investors to convert the Notes at the then current conversion price at any time after 90 days from the issue date if the Common Stock has a closing bid price of $1.55 per share or higher on any twenty (20) days within a thirty (30) day period of consecutive trading days, or if a “fundamental change” occurs (as defined in the Securities Purchase Agreement)
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	78000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	15620	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2024Q1	tomz	Convertible Notes Payable Gross ConvertibleNotesPayableGross	2600000	usd
CY2023Q4	tomz	Convertible Notes Payable Gross ConvertibleNotesPayableGross	2600000	usd
CY2023Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	312398	usd
CY2024Q1	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	312398	usd
CY2024Q1	us-gaap	Ground Leases Accumulated Amortization GroundLeasesAccumulatedAmortization	26032	usd
CY2023Q4	us-gaap	Ground Leases Accumulated Amortization GroundLeasesAccumulatedAmortization	10413	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2313634	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2298015	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	580042	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	580042	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.43
CY2024Q1	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	30000	usd
CY2024Q1	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	0	usd
CY2024Q1	us-gaap	Contractual Obligation ContractualObligation	30000	usd
CY2023Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	30000	usd
CY2022Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	68000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	3962	usd
CY2023	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	26911	usd
CY2024Q1	tomz	Settlement Of Warranty Claims SettlementOfWarrantyClaims	3962	usd
CY2023	tomz	Settlement Of Warranty Claims SettlementOfWarrantyClaims	64911	usd
CY2024Q1	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	30000	usd
CY2023Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	30000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	tomz	Net Deferred Tax Assets Valuation Allowance NetDeferredTaxAssetsValuationAllowance	-7851000	usd
CY2023Q4	tomz	Net Deferred Tax Assets Valuation Allowance NetDeferredTaxAssetsValuationAllowance	-7539000	usd
CY2024Q1	tomz	Description Of Valuation Allowance DescriptionOfValuationAllowance	Management believes that based on the available information, it is more likely than not that the remaining U.S. deferred tax assets

Files In Submission

Name	View Source	Status
0001654954-24-006405-index-headers.html	Edgar Link	pending
0001654954-24-006405-index.html	Edgar Link	pending
0001654954-24-006405.txt	Edgar Link	pending
0001654954-24-006405-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tomz-20240331.xsd	Edgar Link	pending
tomz_10q.htm	Edgar Link	pending
tomz_10qimg3.jpg	Edgar Link	pending
tomz_ex311.htm	Edgar Link	pending
tomz_ex312.htm	Edgar Link	pending
tomz_ex321.htm	Edgar Link	pending
tomz_ex322.htm	Edgar Link	pending
tomz-20240331_cal.xml	Edgar Link	unprocessable
tomz-20240331_def.xml	Edgar Link	unprocessable
tomz-20240331_lab.xml	Edgar Link	unprocessable
tomz-20240331_pre.xml	Edgar Link	unprocessable
tomz_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TOMZ
TOMI Environmental Solutions, Inc. Stock $tomz

2024 Q2 Form 10-Q Financial Statement

#000165495424006405 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TOMZ TOMI Environmental Solutions, Inc. Stock $tomz

2024 Q2 Form 10-Q Financial Statement

#000165495424006405 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TOMZ
TOMI Environmental Solutions, Inc. Stock $tomz